Health · 5 views
New pill combo approved for breast cancer that stops responding to hormone therapy
People with advanced breast cancer that has stopped responding to hormone therapy now have a new pill-based treatment option. The U.S.
Summary
People with advanced breast cancer that has stopped responding to hormone therapy now have a new pill-based treatment option. The U.S. Food and Drug Administration (FDA) approved giredestrant (Wilserdly), a once-daily pill, on Monday. It's meant to be taken with the cancer drug everolimus.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- STAT+: GOP, MAHA leaders clash over FDA nominee’s record on vapesContinue reading
- Sleep paralysis: when you’re awake, but can’t move – or even breathe | LettersContinue reading
- U.S. officially loses measles elimination status: "What a tragedy"Continue reading
- New tool enables early intervention for diabetic foot ulcersContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow